Issue Navigation
-
Policy Forum
-
95-100
Mei L, Tang Q, Cui YM, Tobe RG, Selotlegeng L, Ali AH, Xu LZ
Drug Discov Ther. 2013; 7(3):95-100.
DOI: 10.5582/ddt.2013.v7.3.95
-
101-104
A new phenoxazine derivative isolated from marine sediment actinomycetes, Nocardiopsis sp. 236.
Lu CH, Li YY, Wang HX, Wang BM, Shen YM
Drug Discov Ther. 2013; 7(3):101-104.
DOI: 10.5582/ddt.2013.v7.3.101
-
105-108
Hirotani Y, Okumura K, Yoko U, Myotoku M
Drug Discov Ther. 2013; 7(3):105-108.
DOI: 10.5582/ddt.2013.v7.3.105
-
109-115
Chilampalli C, Zhang X, Kaushik RS, Young A, Zeman D, Hildreth MB, Fahmy H, Dwivedi C
Drug Discov Ther. 2013; 7(3):109-115.
DOI: 10.5582/ddt.2013.v7.3.109
-
116-123
Evaluation of in vitro mutagenicity and genotoxicity of magnetite nanoparticles.
Gomaa IO, Kader MHA, Salah TA, Heikal OA
Drug Discov Ther. 2013; 7(3):116-123.
DOI: 10.5582/ddt.2013.v7.3.116
-
124-125
The first inhibitor-based fluorescent imaging probe for aminopeptidase N.
Chen LZ, Du LP, Li MY
Drug Discov Ther. 2013; 7(3):124-125.
DOI: 10.5582/ddt.2013.v7.3.124
-
126-128
Rare disease patients in China anticipate the sunlight of legislation.
Gao JJ, Song PP, Tang W
Drug Discov Ther. 2013; 7(3):126-128.
DOI: 10.5582/ddt.2013.v7.3.126